Prevalence and risk factors for proteinuria: The National Kidney Foundation of Malaysia Lifecheck Health Screening programme

Nephrology

Volumn 18, Issue 8, 2013, Pages 569-575

  Ong, Loke Meng ^a   Punithavathi, Narayanan ^a   Thurairatnam, Dharminy ^a   Zainal, Hadzlinda ^a   Beh, Mei Li ^e   Morad, Zaki ^b   Lee, Sharleen Ys ^b   Bavanandan, Sunita ^c   Kok, Lai Sun ^d  

^a Penang Hospital   (Malaysia)

^b National Kidney Foundation of Malaysia   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d Seberang Jaya Hospital   (Malaysia)

^e Info kinetics Ltd   (Malaysia)

Author keywords

epidemiology; population studies; proteinuria

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; EXERCISE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATURIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MASS SCREENING; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; URINALYSIS; WAIST CIRCUMFERENCE;

EID: 84881386977     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12112     Document Type: Article

References (37)

1. Lim YN, Ong LM, Goh BL,. Nineteenth Report of the Malaysian Dialysis and Transplant 2011, Kuala Lumpur 2012.
2. Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996; 49: 800-805. (Pubitemid 26093091)
3. Ishani A, Grandits GA, Grimm RH, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J. Am. Soc. Nephrol. 2006; 17: 1444-1452. (Pubitemid 43673426)
4. Lea J, Greene T, Hebert L, Lipkowitz M, et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American study of kidney disease and hypertension. Arch. Intern. Med. 2005; 165: 947-953. (Pubitemid 40563243)
5. Remuzzi G, Bertani T,. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int. 1990; 38: 384-394. (Pubitemid 20258739)
6. Freckmann G, Baumstark A, Jendrike N, et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol. Ther. 2010; 12: 221-231.
7. Panz VR, Raal FJ, Paiker J, et al. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc. J. S. Afr. 2005; 16: 112-117. (Pubitemid 41103512)
8. Park HR, Jeong BK, Park NW,. Comparative evaluation of dipstick urinalysis by dipstick readers. J. Clin. Pathol. Qual. Control 2001; 23: 239-246.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36 (Suppl 1): S67-74.
10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
11. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003; 41: 1-12. (Pubitemid 36043346)
12. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
13. Ramirez SP, McClellan W, Port FK, et al. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J. Am. Soc. Nephrol. 2002; 13: 1907-1917. (Pubitemid 34700617)
14. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J. Am. Soc. Nephrol. 2003; 14 (7 Suppl 2): S131-138. (Pubitemid 36750508)
15. Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003; 63: 1468-1474. (Pubitemid 36350012)
16. Li PK, Kwan BC, Leung CB, et al. Hong Kong Society of nephrology Prevalence of silent kidney disease in Hong Kong: The Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int. 2005; (94): S36-40.
17. Prodjosudjadi W, Suhardjono, Suwitra K, et al. Detection and prevention of chronic kidney disease in Indonesia: Initial community screening. Nephrology (Carlton) 2009; 14: 669-674.
18. U S Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.
19. Moyer JH, Heider C, Pevey K, et al. The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function. Am. J. Med. 1958; 24: 177-192.
20. Fogo A, Breyer JA, Smith MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int. 1997; 51: 244-252. (Pubitemid 27064543)
21. Foley RN, Parfrey PS, Sarnak MJ,. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998; 5 (Suppl 3): S112-119. (Pubitemid 28527268)
22. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: A systematic review. J. Am. Soc. Nephrol. 2006; 17: 2034-2047. (Pubitemid 44036188)
23. Weir MR,. Microalbuminuria and cardiovascular disease. Clin. J. Am. Soc. Nephrol. 2007; 2: 581-590.
24. Sabanayagam C, Lim SC, Wong TY, et al. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol. Dial. Transplant. 2010; 25: 2564-2570.
25. Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, et al. Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med. J. Malaysia 2010; 65: 180-186.
26. Kee CC Jr, Jamaiyah H, Noor Safiza MN, et al. Abdominal Obesity in Malaysian Adults: National Health and Morbidity Survey III (NHMS III, 2006). Malays. J. Nutr. 2008; 14: 125-135.
27. Khoo KL, Tan H, Khoo TH,. Cardiovascular mortality in Peninsular Malaysia: 1950-1989. Med. J. Malaysia 1991; 46: 7-20.
28. Hughes K, Lun KC, Yeo PPB,. Cardiovascular disease in Chinese Malays and Indian in Singapore: Difference in mortality. J. Epidemiol. Community Health 1990; 44: 24-28. (Pubitemid 20104668)
29. Rajadurai J, Arokiasami J, Pasamanichan K, et al. Coronary disease in Asians. Aust. N. Z. J. Med. 1992; 22: 345-348.
30. Hughes LO, Cruickshank JK, Wright J, et al. Disturbances of insulin in British Asian and white men surviving myocardial infarction. BMJ 1989; 299: 537-541. (Pubitemid 19212330)
31. Sheth T, Nair C, Nargundkar M, et al. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: An analysis of 1.2 million deaths. CMAJ 1999; 161: 132-138. (Pubitemid 29375967)
32. Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 2011; 306: 729-736.
33. Ng KL, Htun TH, Dublin N, et al. Assessment and clinical significance of haematuria in Malaysian patients-relevance to early cancer diagnosis. Asian Pac. J. Cancer Prev. 2012; 13: 2515-2518.
34. Department of Statistics, Malaysia. Population distribution and basic demographic characteristic report 2010, updated 5 Aug 2011, [Cited 29 April 2013.], http://www.statistics.gov.my
35. Miltényi M, Körner A, Dobos M, et al. Reversible tubular proteinuria associated with hyperglycemic ketoacidosis in type 1 diabetes mellitus. Int. J. Pediatr. Nephrol. 1983; 4: 247-250. (Pubitemid 14158383)
36. Shephard MDS,. Point-of-care testing and creatinine measurement. Clin. Biochem. Rev. 2011; 32: 109-114.
37. Li PK, Chow KM, Matsuo S, et al. Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology (Carlton) 2011; 16: 633-641.